Yoshinobu Matsuda
Overview
Explore the profile of Yoshinobu Matsuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takemura M, Niki K, Okamoto Y, Matsuda Y, Omae T, Kohno M, et al.
J Opioid Manag
. 2025 Mar;
21(1):61-70.
PMID: 40071699
Objective: Methadone may cause detrimental side effects such as corrected QT (QTc) prolongation. However, methadone may be desirable in patients with advanced cancer and those with heart disease who have...
2.
Nakano K, Kanno Y, Kajiwara K, Kobayashi M, Morikawa M, Matsuda Y, et al.
Palliat Med Rep
. 2025 Feb;
6(1):1-5.
PMID: 40008393
Purpose: This study investigated the frequency with which nursing support for constipation is provided for patients with cancer during the prognostic months and weeks. Methods: An online cross-sectional survey was...
3.
Hasegawa T, Mori M, Yamaguchi T, Imai K, Matsuda Y, Maeda I, et al.
Cancer Med
. 2025 Feb;
14(3):e70677.
PMID: 39931840
Introduction: Systemic opioids are recommended as a pharmacological treatment for dyspnea, and antipsychotics are widely used for delirium. Because little is known about optimal palliative pharmacological strategies for dyspnea in...
4.
Amano K, Koshimoto S, Okamura S, Sakaguchi T, Arakawa S, Matsuda Y, et al.
Healthcare (Basel)
. 2025 Jan;
12(24.
PMID: 39765960
Background: Serum C-reactive protein (CRP) levels are correlated with patient outcomes in cancer. This study aimed to determine associations between the CRP level and the dietary intake, symptoms, and eating-related...
5.
Kanno Y, Nakano K, Kajiwara K, Kobayashi M, Morikawa M, Matsuda Y, et al.
Am J Hosp Palliat Care
. 2025 Jan;
:10499091241312344.
PMID: 39752729
Background: Delirium is a condition characterized by an acute and transient disturbance in attention, cognition, and consciousness. It is increasingly prevalent at the end of life in patients with cancer....
6.
Hasegawa T, Mori M, Yamaguchi T, Imai K, Matsuda Y, Maeda I, et al.
J Palliat Med
. 2024 Dec;
PMID: 39636712
Altered cognitive function due to delirium changes the threshold or tolerance of symptoms. The impacts of delirium motor subtypes on symptoms remain unknown. Determining whether delirium motor subtypes are associated...
7.
Koyauchi T, Fujisawa T, Miyashita M, Mori M, Morita T, Yazawa S, et al.
Ann Am Thorac Soc
. 2024 Nov;
22(3):395-402.
PMID: 39513985
Accurate prognostic awareness (PA) and knowledge of the disease are critical for decision-making regarding treatment options, advance care planning, and end-of-life care. However, they have not been investigated in patients...
8.
Kajiwara K, Kobayashi M, Nakano K, Kanno Y, Morikawa M, Matsuda Y, et al.
Palliat Med Rep
. 2024 Oct;
5(1):425-429.
PMID: 39463824
Purpose: This study explores the use of nursing support among nurses for caregiver burden in family caregivers of terminally ill patients with cancer in palliative care units (PCUs). Methods: Requests...
9.
Niki K, Okamoto Y, Yasui M, Omae T, Kohno M, Matsuda Y
Palliat Med Rep
. 2024 Oct;
5(1):430-437.
PMID: 39440112
Background: To address the need for short-term prognostic methods using objective measures, we developed a method to predict a 2- or 3-week prognosis using only six clinical tests (known as...
10.
Kako J, Morikawa M, Kajiwara K, Kobayashi M, Kanno Y, Nakano K, et al.
Palliat Med Rep
. 2024 Oct;
5(1):440-444.
PMID: 39440109
Background And Purpose: Dyspnea in patients with terminal cancer worsens near death, necessitating effective nonpharmacological management. Despite guideline recommendations, detailed studies on nonpharmacological nursing practices are scarce. This study aimed...